 |
CTSI Translational Science Poster Session - Save the Date |
Please join us on March 16th from 3 pm to 5:30 pm for the 9th Annual CTSI Translational Science Poster Session. Posters from all areas of translational research will be presented. See the list of Poster Abstracts here.
The Zoom Meeting link will be posted on the symposium webpage.
|
|
|
|
|
3rd Thursday Community Engagement Education Series |
Session 3: What CE Researchers at BU and BMC Need to Know About Subcontracting with Community Partners
Mar. 18, 2021, 12 - 1 p.m.
Presented by Stephanie Wasserman, CRA, MHA,
Renna Lilly, & Shelly Stewardson
|
Representatives from BU and BMC Sponsored Programs and Research Operations will help CE Researchers understand administrative structures at the university and hospital levels involved in subcontracting with community partners.
|
|
|
|
|
Session 3: Recruitment and Retention of Populations Underrepresented
and Historically Excluded from Research
Mar. 25, 2021, 12 - 1 p.m.
Presented by Caroline J. Kistin, MD, MSc, Jocelyn Antonio,
Sarah Bagley, MD, MSc, & Katherine Bright, MA
The goal of this series is to provide an understanding of the ethical background, regulatory knowledge, and models of best practices for conducting research when the participants represent special populations and vulnerable subjects.
|
|
|
|
|
Advancing Health Literacy to Enhance Equitable Community Responses to COVID-19
Award Amount: up to $4,000,000 for urban communities; up to $3,000,000 for rural communities
Estimated Total: $250,000,000
|
|
|
|
|
Notice of Special Interest (NOSI): Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care
National Institute on Minority Health and Health Disparities (NIMHD)
|
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy
National Institute of General Medical Sciences (NIGMS)
|
|
|
|
Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration
National Institute on Aging (NIA)
|
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
|
|
|
|
Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional)
National Institute on Drug Abuse (NIDA)
|
Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute (NHLBI)
|
|
|
|
|
UNITE: A New NIH Initiative to End Structural Racism and Achieve Racial Equity in the Biomedical Research Enterprise.
NIH is in a position of influence to contribute to positive, visible, and sustainable change to break the cycle of institutional racism with systems, policies, social norms, and practices that remove stereotypes and mitigate the pervasive effects of racism. Read More
|
|
|
|
|
Delayed Local Reactions to mRNA-1273 Vaccine Against SARS-CoV-2
These reactions are likely to generate concerns among patients and requests for evaluation. These reactions have not been consistently recognized, guidance regarding the second dose of vaccine has varied, and many patients have unnecessarily received antibiotic agents. Read More
|
|
|
|
|
Antibody Response Affects COVID-19 Outcomes in Kids and Adults
Thankfully, the vast majority of kids with COVID-19 don’t get sick or show only mild flu-like symptoms. But a small percentage develop a delayed, but extremely troubling, syndrome called multisystem inflammatory syndrome in children (MIS-C). Read More
|
|
|
|
|
COVID-19 Can Derange the Immune System in Complex Ways, Research Shows. Here's how.
In some COVID-19 patients, this education may be cut short. Scientists say unprepared immune cells appear to be responding to the coronavirus with a devastating release of chemicals, inflicting damage that may endure long after the threat has been eliminated. Read More
|
|
|
|
|
Mathematical Model of SARS-CoV-2 UK Variant Suggests it Could be 43–90% More Transmissible
In a study published in the journal Science
in November of last year, medical researchers discovered a new variant of the SARS-CoV-2 virus, which subsequently became known as the VOC 202012/01 (U.K.) variant. Read More
|
|
|
|
|
How to Utilize Real-World Data to Support Your Research and Clinical Trials
Mar. 11, 2021
You are invited to attend two upcoming training webinars to learn how to utilize the TriNetX platform to conduct research and support clinical trials utilizing real-world data. More Details Here.
|
|
|
|
|
The New Health IT: Post-Pandemic Capabilities and Challenges
Mar. 17, 2021, 12 - 1 p.m.
|
In this presentation, we will share the lessons learned on how effective IT support enabled a large health system to manage the pandemic and the current surge in demand for care and vaccinations. The pandemic has forced healthcare IT departments to become more agile and deliver new functionality in near real-time. Development efforts that traditionally took months were compressed into weeks.
|
|
|
|
|
Mar. 17, 2021, 3 - 4 p.m.
At this workshop for early-career faculty, participants will be introduced to the wide range of resources and support provided by BU's Federal Relations and Foundation Relations teams, with a focus on early-career funding roadmaps. Attendees can expect to walk away with critical tools for identifying and securing external funding for their research. More Details Here
|
|
|
|
|
HRSA's March Virtual Job Fair
Mar. 24, 2021, 6:30 p.m.
HRSA Virtual Job Fairs are free online recruitment events that connect students and clinicians with health care delivery organizations. During the fair, you will learn about available training and employment opportunities across the country, benefits packages offered, and general information about patient populations.
|
|
|
|
|
|
Accelerating Discoveries Towards Better Health
|
|
|
|
|
|
|
